[
  {
    "ts": null,
    "headline": "Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook",
    "summary": "Zimmer’s CEO said its 2026 outlook remains cautious as it focuses on product adoption, a US salesforce transition, and international market performance.",
    "url": "https://finnhub.io/api/news?id=2cd2b6190b7228f78b6ddde351198d05328c0bcf649db828c15e70579351e110",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770746150,
      "headline": "Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook",
      "id": 139033791,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer’s CEO said its 2026 outlook remains cautious as it focuses on product adoption, a US salesforce transition, and international market performance.",
      "url": "https://finnhub.io/api/news?id=2cd2b6190b7228f78b6ddde351198d05328c0bcf649db828c15e70579351e110"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market",
    "summary": "Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.",
    "url": "https://finnhub.io/api/news?id=681694eb59e98bb529856d81daafb06586fa5782a5a2b80b4a5d52320afc2181",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770739860,
      "headline": "ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market",
      "id": 139033680,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.",
      "url": "https://finnhub.io/api/news?id=681694eb59e98bb529856d81daafb06586fa5782a5a2b80b4a5d52320afc2181"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript",
    "summary": "Ivan Tornos: Good morning, everyone, and thank you for joining today's call.  Today, Zimmer Biomet is a totally different company than it was just a few short years ago, and this is no doubt due to your efforts.  Starting with the year and the fourth quarter, I'm proud of how the team ended the year 2025, delivering on our commitments on sales growth, EPS, and free cash flow while navigating quite a complex challenge in the year.",
    "url": "https://finnhub.io/api/news?id=e7ffc7317bfc76b281c5f9892a79f11463c40c69634adcfa02635896e538cf6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770736043,
      "headline": "Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript",
      "id": 139032192,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Ivan Tornos: Good morning, everyone, and thank you for joining today's call.  Today, Zimmer Biomet is a totally different company than it was just a few short years ago, and this is no doubt due to your efforts.  Starting with the year and the fourth quarter, I'm proud of how the team ended the year 2025, delivering on our commitments on sales growth, EPS, and free cash flow while navigating quite a complex challenge in the year.",
      "url": "https://finnhub.io/api/news?id=e7ffc7317bfc76b281c5f9892a79f11463c40c69634adcfa02635896e538cf6a"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=5b3c5842757b05f2faa0d0b4481b0f602813b266ce4350194d7c266db64638de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770733804,
      "headline": "Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 139032193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=5b3c5842757b05f2faa0d0b4481b0f602813b266ce4350194d7c266db64638de"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet beats quarterly estimates on strong hips, knees device demand",
    "summary": "Feb 10 () - Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company capitalized ​on steady demand for its devices used in orthopedic procedures. Shares ‌of the Warsaw, Indiana based company rose 1.",
    "url": "https://finnhub.io/api/news?id=dd5faa3447c851a03de95fc790c577fe275274621291dddc68fa59536a32a9c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770729543,
      "headline": "Zimmer Biomet beats quarterly estimates on strong hips, knees device demand",
      "id": 139030132,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Feb 10 () - Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company capitalized ​on steady demand for its devices used in orthopedic procedures. Shares ‌of the Warsaw, Indiana based company rose 1.",
      "url": "https://finnhub.io/api/news?id=dd5faa3447c851a03de95fc790c577fe275274621291dddc68fa59536a32a9c7"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript",
    "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call February 10, 2026 8:30 AM ESTCompany ParticipantsDavid DeMartino - Senior Vice President of...",
    "url": "https://finnhub.io/api/news?id=47d05257c933d99a7daad8b057325a0a6c6a65e0a20567ddaa2306f6ce8de6c4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770728663,
      "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript",
      "id": 139033859,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZBH",
      "source": "SeekingAlpha",
      "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call February 10, 2026 8:30 AM ESTCompany ParticipantsDavid DeMartino - Senior Vice President of...",
      "url": "https://finnhub.io/api/news?id=47d05257c933d99a7daad8b057325a0a6c6a65e0a20567ddaa2306f6ce8de6c4"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates",
    "summary": "Zimmer (ZBH) delivered earnings and revenue surprises of +1.70% and +1.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=5c14de0b232dd444e4ee0cfa7c3e4ec0497b1ce37e203621aebc7093ba97a933",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770727203,
      "headline": "Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates",
      "id": 139032194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer (ZBH) delivered earnings and revenue surprises of +1.70% and +1.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=5c14de0b232dd444e4ee0cfa7c3e4ec0497b1ce37e203621aebc7093ba97a933"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations",
    "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per share was 0.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=564ef10867e6bd7ef533d6d631d03a3c5cda43bd5d0397af203d25a7fa1962f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770723904,
      "headline": "Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations",
      "id": 139030133,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per share was 0.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=564ef10867e6bd7ef533d6d631d03a3c5cda43bd5d0397af203d25a7fa1962f4"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer: Q4 Earnings Snapshot",
    "summary": "The Warsaw, Indiana-based company said it had net income of 70 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $2.42 per share. The results beat Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=3cbf28f436645436cd5810b474da5c4c16d8a847580cb8f7ad64f688bf61896a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770723396,
      "headline": "Zimmer: Q4 Earnings Snapshot",
      "id": 139028537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "The Warsaw, Indiana-based company said it had net income of 70 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $2.42 per share. The results beat Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=3cbf28f436645436cd5810b474da5c4c16d8a847580cb8f7ad64f688bf61896a"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025. The Company reported fourth quarter net sales of $2.244 billion, an increase of 10.9% over the prior year period, an increase of 9.2% on a constant currency1 basis and an increase of 5.4% on an organic constant currency1 basis. Net sales for the full year were $8.232 billion, an increase of 7.2% over the prior year, an increase of 6.4% on a constant currency1 basis",
    "url": "https://finnhub.io/api/news?id=6e5af29b534512cf0cc63e4276f553798b148bfe8441e7a6897b6f4dde602836",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770723000,
      "headline": "Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results",
      "id": 139028538,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025. The Company reported fourth quarter net sales of $2.244 billion, an increase of 10.9% over the prior year period, an increase of 9.2% on a constant currency1 basis and an increase of 5.4% on an organic constant currency1 basis. Net sales for the full year were $8.232 billion, an increase of 7.2% over the prior year, an increase of 6.4% on a constant currency1 basis",
      "url": "https://finnhub.io/api/news?id=6e5af29b534512cf0cc63e4276f553798b148bfe8441e7a6897b6f4dde602836"
    }
  },
  {
    "ts": null,
    "headline": "Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data",
    "summary": "Precedence Research, a leading strategic research firm, presents an in-depth analysis of the Tissue and Regenerative Engineering market, highlighting key company performance, product focus, and government funding initiatives. Tissue engineering and regenerative biomaterials are advancing rapidly, with innovations in scaffolds, bio-inks, and engineered tissues enabling applications in wound healing, reconstructive surgery, and orthopedic repair.Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According",
    "url": "https://finnhub.io/api/news?id=d8db969f7db8599f04cbe95434718f05aabbf494e879404eb8729ef924c4bc39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770717660,
      "headline": "Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data",
      "id": 139028539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Precedence Research, a leading strategic research firm, presents an in-depth analysis of the Tissue and Regenerative Engineering market, highlighting key company performance, product focus, and government funding initiatives. Tissue engineering and regenerative biomaterials are advancing rapidly, with innovations in scaffolds, bio-inks, and engineered tissues enabling applications in wound healing, reconstructive surgery, and orthopedic repair.Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According",
      "url": "https://finnhub.io/api/news?id=d8db969f7db8599f04cbe95434718f05aabbf494e879404eb8729ef924c4bc39"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Sees FY2026 Adj EPS $8.30-$8.45 vs $8.48 Est; Sees Sales $8.437B-$8.602B vs $8.612B Est",
    "summary": "Zimmer Biomet Holdings (NYSE:ZBH) is looking for FY2026 Adj EPS of $8.30-$8.45 vs $8.48 analyst estimate. sees sales of $8.437 billion-$8.602 billion vs $8.612 billion analyst estimate.",
    "url": "https://finnhub.io/api/news?id=a65d9a27e2f10d47f532dbeccd7654fec20b7bf852f4d079dbe437d030cef92e",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770708767,
      "headline": "Zimmer Biomet Holdings Sees FY2026 Adj EPS $8.30-$8.45 vs $8.48 Est; Sees Sales $8.437B-$8.602B vs $8.612B Est",
      "id": 139029020,
      "image": "",
      "related": "ZBH",
      "source": "Benzinga",
      "summary": "Zimmer Biomet Holdings (NYSE:ZBH) is looking for FY2026 Adj EPS of $8.30-$8.45 vs $8.48 analyst estimate. sees sales of $8.437 billion-$8.602 billion vs $8.612 billion analyst estimate.",
      "url": "https://finnhub.io/api/news?id=a65d9a27e2f10d47f532dbeccd7654fec20b7bf852f4d079dbe437d030cef92e"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Q4 Earnings Assessment",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=605ac37de6dbd66cd08ce87a9c56100f0d75826c0ced9f0c1ece638d8a3cd30c",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770708737,
      "headline": "Zimmer Biomet Holdings Q4 Earnings Assessment",
      "id": 139029021,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg?width=2048&height=1536",
      "related": "ZBH",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=605ac37de6dbd66cd08ce87a9c56100f0d75826c0ced9f0c1ece638d8a3cd30c"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Q4 Adj. EPS $2.42 Beats $2.40 Estimate, Sales $2.244B Beat $2.231B Estimate",
    "summary": "Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.42 per share which beat the analyst consensus estimate of $2.40 by 1 percent. This is a 4.76 percent increase over earnings of $2.31 per share from the",
    "url": "https://finnhub.io/api/news?id=e6fd6d82f76082e439a4d2493e634612ba3cd093ff586549ee3327d7caa5f773",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770708683,
      "headline": "Zimmer Biomet Holdings Q4 Adj. EPS $2.42 Beats $2.40 Estimate, Sales $2.244B Beat $2.231B Estimate",
      "id": 139029022,
      "image": "",
      "related": "ZBH",
      "source": "Benzinga",
      "summary": "Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.42 per share which beat the analyst consensus estimate of $2.40 by 1 percent. This is a 4.76 percent increase over earnings of $2.31 per share from the",
      "url": "https://finnhub.io/api/news?id=e6fd6d82f76082e439a4d2493e634612ba3cd093ff586549ee3327d7caa5f773"
    }
  },
  {
    "ts": null,
    "headline": "Earnings Scheduled For February 10, 2026",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=34cdaa667719ebb868aab7df7cb89a13599504085c8554c65ca0fc74f16d2453",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770707478,
      "headline": "Earnings Scheduled For February 10, 2026",
      "id": 139029023,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
      "related": "ZBH",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=34cdaa667719ebb868aab7df7cb89a13599504085c8554c65ca0fc74f16d2453"
    }
  },
  {
    "ts": null,
    "headline": "The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports",
    "summary": "The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports",
    "url": "https://finnhub.io/api/news?id=b542bb582236d83bb0ccac76b39dac3a8d6d89d299263f31ac176f1df50ac620",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770701400,
      "headline": "The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports",
      "id": 139028049,
      "image": "",
      "related": "ZBH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b542bb582236d83bb0ccac76b39dac3a8d6d89d299263f31ac176f1df50ac620"
    }
  }
]